Urogenitale Tumoren
4 StudienEV-302 / KEYNOTE-A392024Enfortumab Vedotin + Pembrolizumab in Advanced Urothelial CarcinomaVISION2021177Lu-PSMA-617 in PSMA-Positive Metastatic Castration-Resistant Prostate CancerCheckMate-2142018Nivolumab + Ipilimumab in Advanced Renal Cell CarcinomaCHAARTED2015ADT + Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer